Statistics

Total Visits

Views
Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by77

Select a period of time:

Number of views in the range

Views
Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by35

Views

Views
December 20255
January 20266
February 20261
March 202610
April 202610
May 20263
June 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States18
Brazil4
Argentina3
Canada2
China1
Germany1
Finland1
France1
South Korea1
Mexico1
 

Top cities views

Views
San Jose4
Ashburn2
Apex1
Bauru1
Buenos Aires1
Cleveland1
Delmiro Gouveia1
Frankfurt am Main1
Fresno1
Helsinki1